1. Home
  2. ADXN vs SILO Comparison

ADXN vs SILO Comparison

Compare ADXN & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • SILO
  • Stock Information
  • Founded
  • ADXN 2002
  • SILO 2010
  • Country
  • ADXN Switzerland
  • SILO United States
  • Employees
  • ADXN N/A
  • SILO N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • SILO Apparel
  • Sector
  • ADXN Health Care
  • SILO Consumer Discretionary
  • Exchange
  • ADXN Nasdaq
  • SILO Nasdaq
  • Market Cap
  • ADXN 8.0M
  • SILO 8.8M
  • IPO Year
  • ADXN N/A
  • SILO N/A
  • Fundamental
  • Price
  • ADXN $7.59
  • SILO $1.65
  • Analyst Decision
  • ADXN Strong Buy
  • SILO
  • Analyst Count
  • ADXN 1
  • SILO 0
  • Target Price
  • ADXN $30.00
  • SILO N/A
  • AVG Volume (30 Days)
  • ADXN 24.6K
  • SILO 805.4K
  • Earning Date
  • ADXN 03-24-2025
  • SILO 02-18-2025
  • Dividend Yield
  • ADXN N/A
  • SILO N/A
  • EPS Growth
  • ADXN N/A
  • SILO N/A
  • EPS
  • ADXN 0.06
  • SILO N/A
  • Revenue
  • ADXN $701,260.00
  • SILO $72,102.00
  • Revenue This Year
  • ADXN N/A
  • SILO $1.86
  • Revenue Next Year
  • ADXN N/A
  • SILO N/A
  • P/E Ratio
  • ADXN $1.04
  • SILO N/A
  • Revenue Growth
  • ADXN N/A
  • SILO N/A
  • 52 Week Low
  • ADXN $6.81
  • SILO $0.77
  • 52 Week High
  • ADXN $27.90
  • SILO $4.50
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 48.97
  • SILO 52.57
  • Support Level
  • ADXN $7.20
  • SILO $1.56
  • Resistance Level
  • ADXN $8.04
  • SILO $1.89
  • Average True Range (ATR)
  • ADXN 0.51
  • SILO 0.19
  • MACD
  • ADXN 0.00
  • SILO -0.05
  • Stochastic Oscillator
  • ADXN 47.95
  • SILO 27.12

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: